Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics

CORT POWR Grades

• CORT scores best on the Quality dimension, with a Quality rank ahead of 99.57% of US stocks.
• The strongest trend for CORT is in Stability, which has been heading down over the past 179 days.
• CORT's current lowest rank is in the Momentum metric (where it is better than 12.28% of US stocks).

CORT Stock Summary

• The ratio of debt to operating expenses for Corcept Therapeutics Inc is higher than it is for about merely 4.94% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.09 for Corcept Therapeutics Inc; that's greater than it is for only 8.1% of US stocks.
• With a year-over-year growth in debt of -79.38%, Corcept Therapeutics Inc's debt growth rate surpasses only 3.19% of about US stocks.
• Stocks that are quantitatively similar to CORT, based on their financial statements, market capitalization, and price volatility, are HRTX, CCXI, QUIK, OLED, and BLI.
• CORT's SEC filings can be seen here. And to visit Corcept Therapeutics Inc's official web site, go to www.corcept.com.

CORT Valuation Summary

• In comparison to the median Healthcare stock, CORT's EV/EBIT ratio is 24.23% lower, now standing at 22.2.
• CORT's EV/EBIT ratio has moved up 50.1 over the prior 212 months.
• CORT's price/sales ratio has moved NA NA over the prior 212 months.

Below are key valuation metrics over time for CORT.

CORT Growth Metrics

The 5 year cash and equivalents growth rate now stands at 107.34%.
• The 3 year price growth rate now stands at 140.21%.
• Its year over year cash and equivalents growth rate is now at -37.99%.

CORT's revenue has moved up $9,944,000 over the prior 15 months.

The table below shows CORT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	365.978	167.892	112.512
2021-09-30	352.891	153.536	106.453
2021-06-30	343.087	135.276	97.607
2021-03-31	340.064	144.123	99.411
2020-12-31	353.874	151.97	106.011
2020-09-30	356.034	165.353	109.398

CORT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CORT has a Quality Grade of A, ranking ahead of 98.86% of graded US stocks.
• CORT's asset turnover comes in at 0.616 -- ranking 52nd of 681 Pharmaceutical Products stocks.
• OTIC, ABT, and AVDL are the stocks whose asset turnover ratios are most correlated with CORT.

The table below shows CORT's key quality metrics over time.